| Literature DB >> 23278224 |
Nader Moazami1, Katherine J Hoercher, Kiyotaka Fukamachi, Mariko Kobayashi, Nicholas G Smedira, Alex Massiello, David J Horvath.
Abstract
Heart transplantation remains the gold standard for long-term cardiac replacement, but a shortage of donor organs will always limit this option. For both transplant-eligible and noneligible patients, advances in mechanical circulatory support have revolutionized the options for the management of end-stage heart failure, and this technology continues to bring us closer to a true alternative to heart transplantation. This review provides a perspective on the past, present and future of mechanical circulatory support and addresses the changes in technology, patient selection and management strategies needed to have this therapy fully embraced by the heart failure community, and perhaps replace heart transplantation either as the therapy of choice or as a strategy by which to delay transplantation in younger patients.Entities:
Mesh:
Year: 2013 PMID: 23278224 DOI: 10.1586/erd.12.69
Source DB: PubMed Journal: Expert Rev Med Devices ISSN: 1743-4440 Impact factor: 3.166